Meyka AI API is live for developers.Start building.
Advertisement
BioInvent International AB (publ)

BioInvent International AB (publ) (BOVNF) Stock Overview

Explore BioInvent International AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

BOVNF●PNK
HealthcareBiotechnology
$3.29
$0.00(0.00%)
U.S. Market opens in 6h 24m
Advertisement

BioInvent International AB (publ) (BOVNF)

Meyka AI Score

Z

Key Financials

Market Cap216.4M
P/E Ratio-6.15
EPS (TTM)$-0.47
ROE-0.54%
Fundamental Analysis

AI Price Forecasts

1 Month$3.10
3 Months$3.45
1 Year Target$4.51

BOVNF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioInvent International AB (publ) (BOVNF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $4.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.15 and a market capitalization of 216.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-0.04%
1-Month Change
-0.04%
3-Month Change
-0.04%
6-Month Change
-0.04%
Year-to-Date (YTD) Change
-0.04%
1-Year Change
-0.04%
3-Year Change
-30.03%
5-Year Change
-54.15%
All-Time (Max) Change
-50.17%

Contact Information

https://www.bioinvent.com
46 4 62 86 85 50
The Gamma Building, Lund, NaN, 223 70

Company Facts

114 Employees
IPO DateSep 3, 2013
CountrySE
Actively Trading

Frequently Asked Questions